Company: ABUS
Filing Date: 2025-04-23
Form Type: 8-K
Source: 0001171843-25-002401
Chunk: 0

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-23
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On April 23, 2025, Arbutus Biopharma Corporation (the “ Company”) issued a press release announcing that five abstracts have been accepted for poster presentation, one of which is a late-breaker at the European Association for the Study of the Liver (EASL) Congress 2025 taking place May 7 - 10, 2025 in Amsterdam, Netherlands. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit Number      Description                                                                  
            99.1      Press Release dated April 23, 2025                                           
 ───────────────────────────────────────────────────────────────────────────────────────────────────
             104      Cover Page Interactive Data File (embedded within the Inline XBRL document)